[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5926 Introduced in House (IH)]

<DOC>






115th CONGRESS
  2d Session
                                H. R. 5926

    To require the Secretary of Health and Human Services to issue 
      guidelines for prescribing naloxone, and for other purposes.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                              May 23, 2018

  Mr. Keating (for himself and Mr. Rothfus) introduced the following 
    bill; which was referred to the Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL


 
    To require the Secretary of Health and Human Services to issue 
      guidelines for prescribing naloxone, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Naloxone Guidelines Act of 2018''.

SEC. 2. GUIDELINES FOR PRESCRIBING NALOXONE.

    (a) In General.--Not later than 180 days after the date of the 
enactment of this Act, the Secretary of Health and Human Services shall 
issue guidelines for prescribing an opioid overdose reversal drug.
    (b) Contents.--In issuing guidelines under subsection (a), the 
Secretary shall address the following:
            (1) Co-prescribing an opioid overdose reversal drug in 
        conjunction with any prescribed opioid.
            (2) Dosage safety.
            (3) Prescribing an opioid overdose reversal drug to an 
        individual other than a patient.
            (4) Standing orders.
            (5) Other distribution, education, and safety measures as 
        determined necessary.
                                 <all>